Citadel Advisors’s UpHealth, Inc. UPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-750
Closed -$735 15748
2023
Q3
$735 Buy
+750
New +$1.1K ﹤0.01% 13992
2023
Q1
Sell
-1,890
Closed -$3.08K 16242
2022
Q4
$3.08K Sell
1,890
-330
-15% -$1.28K ﹤0.01% 14253
2022
Q3
$12K Hold
2,220
﹤0.01% 12245
2022
Q2
$13K Sell
2,220
-1,240
-36% -$9.65K ﹤0.01% 12537
2022
Q1
$41K Sell
3,460
-550
-14% -$12.2K ﹤0.01% 12926
2021
Q4
$90K Sell
4,010
-70
-2% -$1.62K ﹤0.01% 12823
2021
Q3
$129K Sell
4,080
-530
-11% -$27.7K ﹤0.01% 12567
2021
Q2
$311K Buy
4,610
+1,080
+31% +$101K ﹤0.01% 11178
2021
Q1
$354K Sell
3,530
-29,350
-89% -$3.03M ﹤0.01% 10466
2020
Q4
$3.6M Buy
+32,880
New +$3.39M ﹤0.01% 4267

Other funds holding UPH

Citadel Advisors's UPH Position: Q4 2023 in Review

Citadel Advisors sold out of UpHealth, Inc. (UPH) in Q4 2023, closing a stake of 8,416 shares — an estimated $8.25K sold.

Citadel Advisors first reported a position in UPH in Q4 2020 and held it in 7 quarters. The position peaked at $3.1M in Q4 2020. 5 funds tracked by Wall St. Rank hold UPH as of Q4 2023.

  • Citadel Advisors reported no remaining UpHealth, Inc. position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 8,416 UpHealth, Inc. shares in Q4 2023, an estimated $8.25K.
  • Citadel Advisors first reported a position in UpHealth, Inc. in Q4 2020 and held it in 7 quarters.
  • Citadel Advisors's UpHealth, Inc. position peaked at $3.1M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.